Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 2 - You Need To See This

2 Cannabis Stocks to Think Twice About Before Buying

The cannabis industry has been facing several economic and regulatory challenges. Demand has also slowed amid a glut in supply. With the Fed unlikely to stop interest rate hikes, the economy could enter a recession this year. Amid this backdrop, it could be wise to avoid fundamentally weak cannabis stocks…

StockNews.com

3 Stocks to Sell Now Before Losses Worsen

Despite the banking industry crisis, the Fed is expected to launch another rate hike next week as it remains committed to bringing inflation down. Therefore, fundamentally weak stocks Snap (SNAP), Peloton Interactive (PTON), and Tilray Brands (TLRY) might be best avoided as they might plunge further. Keep reading.

StockNews.com

2 Risky Cannabis Stocks to Avoid Right Now

Following remarkable growth in recent years, the cannabis industry faced various legal and economic challenges, including overproduction amid high inflation, high taxes, and increased material costs impacting overall sales in 2022. The industry will likely remain under pressure amid concerns over rising inflation and a potential recession. Hence, it could…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Cannabis Stocks to Avoid Like the Plague in March 2023

The cannabis industry faced several challenges last year, including overproduction amid high inflation weighing on overall demand. With growing concerns over rising inflation and a looming recession, the industry is expected to remain under immense pressure this year. So, it could be wise to avoid fundamentally weak cannabis stocks Tilray…

StockNews.com

Marijuana Stocks: Buy or Sell These 3 in 2023?

Although several states have legalized marijuana, the industry faces a supply glut amid high inflation impacting overall demand. With Federal legalization unlikely this year, marijuana stocks could remain under pressure. Therefore, would it be wise to invest in marijuana stocks Tilray Brands (TLRY), Canopy Growth (CGC), and Aurora Cannabis (ACB)…

StockNews.com

Soaring concerns over an impending Fed-induced recession have hampered investor sentiment. With the likelihood of a downturn in upcoming months, are popular stocks Peloton Interactive (PTON), Tilray Brands (TLRY), and ContextLogic (WISH) worth your attention? Read on to find out….

StockNews.com

2 Marijuana Stocks to Sell Short, Liquidate or Avoid in 2023

The marijuana industry took a hit facing economic challenges. With no immediate hope of federal legalization, it may be a while until the U.S. government looks favorably toward pot stocks. Hence, fundamentally weak marijuana stocks Tilray Brands (TLRY) and Canopy Growth (CGC) might be best avoided this year. Continue reading….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

4 Marijuana Stocks to Avoid Like the Plague

While marijuana legalization has been rising, the industry is witnessing increased regulations. Moreover, the sector’s revenues have been declining recently. Hence, marijuana stocks Tilray Brands (TLRY), Canopy Growth (CGC), Sundial Growers (SNDL), and Aurora Cannabis (ACB) might be best avoided, given their weak fundamentals and negative profit margins. Keep reading.

StockNews.com

2 Marijuana Stocks That Are Nothing Short of Buzzkill

While the cannabis industry might be looking at a possible reversal of fortunes due to increased legalization for recreational and proven medicinal usage, fundamentally weak and beaten-down Marijuana stocks Tilray Brands (TLRY) and Canopy Growth (CGC) may be wealth destroyers. So, it could be wise for investors to avoid these…

StockNews.com

North American Cannabis Market: Is Interest Waning In Canada And The US? Here's What A New Report Says

As Benzinga recently reported, sales growth in Canada appears to be stagnating for the cannabis sector. According to Cantor Fitzgerald's Pablo Zuanic, the

Benzinga

Canopy Growth, Tilray Pull Back After Enjoying Surge Following Biden's Pardon: What's Up With These Cannabis Stocks?

Canopy Growth Corp. (NASDAQ: CGC) and Tilray Brands Inc. (NASDAQ: TLRY) were plunging over 13% and 11%, respectively, at one point Friday after skyrocketing on Thursday.

Benzinga

2 Penny Stocks to Avoid Right Now Even at a Discount

With the recent market pullback in the aftermath of Jerome Powell’s speech at Jackson Hole, investors may be tempted to go bottom fishing. However, a rising interest rate environment may not be welcome news for developmental and fund-thirsty businesses with negative cash flows. Thus, given a foreseeably bleak outlook, it…

StockNews.com

3 Cannabis Stocks Going up in Flames to Avoid

The wide use of cannabis for recreational activities and its increased medicinal use has helped the market gain traction over the past years. However, with legalization barriers worldwide, this industry is in an odd limbo in which consumption flourishes, but penalties and taxes still prevail. Given the backdrop, it should…

StockNews.com

EXCLUSIVE: Tilray CEO Shares Insider Insights Into Earnings, International Opportunities, Alcohol Market & More

Tilray Brands Inc.'s (NASDAQ: TLRY) CEO Irwin Simon said on Thursday's "Cannabis Insider" that "Europe will legalize [cannabis] before the U.S."

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

Why Investors Are Starting to Turn Bullish on This 1 Stock

Medical cannabis producer Tilray Brands (TLRY) seems to be attracting investors’ attention lately due to its recent product launches. However, its price target has recently been slashed by Piper Sandler (PIPR). Let’s discuss its prospects in detail.

Benzinga

Tilray Will Cover Employees' Travel, Accommodation & Paid Time Off For Women Seeking Reproductive Care

Tilray Brands Inc. (NASDAQ: TLRY) is joining other companies that are committing to help their employees travel to other states, following SCOTUS' decision to overturn Roe v.

Benzinga

Tilray's Medical Cannabis Brand Aphria Launches Sleep-Oriented CBN Night Oil For Patients In Canada

Tilray Brands, Inc.'s (NASDAQ: TLRY) (TSX:TLRY) medical cannabis brand, Aphria, has launched CBN Night Oil, the brand’s first CBN oil medical product formulated for patients’ nighttime use.

Benzinga

Tilray's Good Supply Brand Expands High-Potency Cannabis Portfolio, Here Are The Details

Tilray Brands, Inc. (Nasdaq: TLRY) (TSX:TLRY) is expanding Good Supply's cannabis portfolio with the launch of new high-potency products including liquid wax vapes and exclusive new

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Irwin Simon, At The Helm Of One Of The Biggest Cannabis Operators, Tilray: Meet Our Keynote Speakers

Who is the person behind the largest Canadian cannabis company in the world? That would be Irwin D. Simon, chairman and CEO of Tilray Brands Inc. (NASDAQ: TLRY).

1 2

People

Mangeet Kaur BounsMangeet

595 stories

Santanu RoyHaving

215 stories

Sristi Suman Jayaswal

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical – Pharmaceuticals

69 stories

CGC

66 stories

Peloton Interactive Inc.

58 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.